3Kugler A, Stuhler G, Walden P, et al. Regression of human meta static renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids. Nat Med, 2000, 6: 332-336.
4Banchereau J, Palucka AK, Dhodapkar M, et al. Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine. Cancer Res, 2001, 61:6451- 6458.
5van den Broeke LT, Daschbach E, Thomas EK, et al. Dendritic cell induced activation of adaptive and innate antitumor immunity. J Immunol, 2003, 171: 5842-5852.
6Mailliard RB, Dallal RM, Son YI, et al. Dendritic cells promote T cell survival or death depending upon their maturation state and presentation of antigen. Immunol Invest, 2000, 29: 177-185.
7Hoffmann TK, Meidenbauer N, Dworacki G et al. Generation of tumor-specific T-lymphocytes by cross-priming with human dendritic cells ingesting apoptotic tumor cells. Cancer Res, 2000, 60: 3542-3549.
8Parasole R, Izzo F, Perrone F, et al. Prognostic value of serum biological markers in patients with hepatocellular carcinoma. Clin Cancer Res, 2001, 7: 3504-3509.
9Chau GY, Wu CW, Lui WY, et al. Serum interleukin-10 but not interleukin-6 is related to clinical outcome in patients with resectable hepatocellular carcinoma. Ann Surg, 2000, 231: 552-558.
10Guo G,Chen S,Zhang J,et al.Antitumor activity of a fusion of esophageal carcinoma cells with dendritic cells derived from cord blood[J].Vaccine,2005,23 (45):5225 ～ 5230.
